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Chitosan/xanthan polyelectrolyte complexes (PECs) are considered promising oral drug 
delivery carriers due to nontoxicity, biodegradability and can be investigated as potential 
carriers for extended drug release [1,2]. Ibuprofen has short half-life (t1/2~2 h) and requires 
frequent administration of immediate release dosage forms [3]. The aim of this study was to 
investigate the influence of the ibuprofen encapsulation procedure on its in vitro release 
kinetics. Dried PECs, prepared with chitosan solutions adjusted to pH 4.6 using acetic acid, and 
ibuprofen dispersed in the xanthan solution before (4.6B) or added after (4.6A) the 
complexation of polymer aqueous solutions, comprising 100 mg of ibuprofen, were filled into 
size 0 capsules. In vitro release profiles in the paddle apparatus (50 rpm) (Erweka DT70, 
Germany) were obtained using 900 ml of phosphate buffer pH 7.2 at 37 ± 1 °C. Both samples 
showed extended ibuprofen release during 12 h. From 4.6B 100% of ibuprofen was released 
after 12 h. From 4.6A 66.41 ± 2.14% of substance was released after the same time. Ibuprofen 
release from the samples followed the Korsmeyer-Peppas kinetics and the release mechanism 
was a combination of swelling, erosion and diffusion (0.5<n<1). PEC 4.6B showed better 
control of ibuprofen release and its preparation conditions are considered optimal for 
controlled extended drug release.  
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